|
Patient medical history includes but is not limited to: hypertension, arteriosclerotic coronary artery disease, heart failure, arthritis, atrial fibrillation, stage 2 kidney disease, diabetes mellitus, stented coronary artery.Patient medications include but are not limited to: albuterol, pantoprazole, diclofenac, furosemide, potassium chloride, prevastatin, trazodone, metoprolol, ibuprofen, metformin, spironolactone, multivitamin.According to the instructions for use (ifu) for the gore® excluder® aaa endoprosthesis; adverse events that may occur include, but are not limited to: endoleak.
|
|
On (b)(6) 2015, this patient underwent endovascular treatment for an abdominal aortic aneurysm and was implanted with gore® excluder® aaa endoprostheses.On (b)(6) 2020, the patient underwent reintervention for a type ii endoleak with aneurysm enlargement (amount unknown) and a gore® aortic extender component was placed proximally, along with two gore® contralateral leg components to reline the graft system.The patient tolerated the procedure and the endoleak was resolved.
|